Today's 8k showing Guizhou Tongren Healthy China Biotechnology Co., Ltd is a subsidiary of ETAH.
On March 26, 2018, Eternity Healthcare Inc. (the “Company”) entered into a Credit Loan Agreement with Shenzhen Dongyang Medical Technology Co., Ltd., as lender, and the Company’s wholly-owned subsidiary, Guizhou Tongren Healthy China Biotechnology Co., Ltd., as borrower (“Tongren Healthy”), pursuant to which the Company agreed to guaranty payment of the indebtedness under a loan facility providing Tongren Healthy with advances for up to $25 million. Advances under the loan facility bear interest at the rate of 10% per annum. The loan facility has a term of five years. A copy of the Credit Loan Agreement is annexed as Exhibit 10.1 to this report.
Click 10.1 Credit Loan Agreement. from today's 8k, that you get the Chinese name of the company
copy the chinese characters and search it on Google.com; you get the following webpage showing company registration info in Chinese http://www.qichacha.com/firm_a23bd0f52c2c9daf3c491dae77e19275.html It clearly shows the subsidiary registration capital is 500M Chinese Yuan, which is around $100M USD
In previous 8k, ETAH issued 17M shares to acquire this $100M subsidiary;
Item 1.01 Entry Into a Material Definitive Agreement
On December 13, 2017, Eternity Healthcare Inc. (the “Company”) entered into a Share Exchange Agreement with the equity holders of Guizho Tongren Healthy China Biotechnology Co. Ltd., a company recently formed to engage in the business of providing stem cell storage and related medical therapies in China. Pursuant to the Agreement, in exchange for all of the outstanding equity in Guizho Tongren Healthy China Biotechnology Co. Ltd., the Company will issue to its current owners 17,181,769 shares of the Company’s common stock. https://backend.otcmarkets.com/otcapi/company/sec-filings/12447247/content/html
News 
Market Data 
Discover 
